The companies say the regulatory conditions of Novo Holdings’ $16.5bn deal with Catalent have been met 

All regulatory closing conditions related to Novo Holdings’ $16.5bn acquisition of US drugmaker Catalent the companies said on Saturday that the deal has been completed, adding that it is expected to close in the coming days.

Share This Post:

POPULAR POSTS
FOLLOW US
Like Us On Facebook
Follow Us On Twitter
Subscribe To Our Channel
TikTok
LIVE STREAM